Variables | Results: Mean (+/− SD) or %. |
Mean disease duration (months) | 76.49 (+/− 87.2) |
Mean diagnostic delay (months) | 38.27 (+/− 78.2) |
Number of painful joints | 5.6 (+/− 7.9) |
Number of swollen joints | 5.02 (+/− 5.4) |
Clinical tenosynovitis (%) | 27.7% |
Number of night awakening | 0.86 (+/− 1.8) |
Morning stiffness duration (minutes) | 30.4 (+/− 37.7) |
Joints deformities (%) | 66 % |
DAS 28 CRP (mean value) | 3.8 (+/− 1.2) |
Extra-articulaire manifestations (%) | 64% |
Positivity of Rheumatoid Factor | 20/30 (66.6%) |
Positivity of anti-CCP | 29/30 (96.6%) |
Prednisone | 98% |
Methotrexate | 70% |
Sulfasalazine | 28% |
Hydroxychloroquine | 50% |
Patients followed by up to 1 DMARD | 34% |